Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05480189

Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world Study

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Zhejiang Cancer Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

non-intervention、real world study; Effect of timing and regular treatment of zoledronic acid on the incidence of SREs in breast cancer patients

Detailed description

(1) Main Purpose: To observe the clinical efficacy of zoledronic acid regularly in the prevention of SREs in breast cancer patients with bone metastasis (2) Secondary Objectives: 1. To observe whether zoledronic acid prolonged the time of first SREs in patients with bone metastasis; 2. The clinical efficacy and influencing factors of zoledronic acid in different subgroups were observed by subgroup analysis of population baseline, clinical characteristics (such as different types of breast cancer), past history and complications. 3. To observe the clinical distribution, characteristics, timing and compliance of zoledronic acid administration in Chinese breast cancer patients with first bone metastasis.

Conditions

Interventions

TypeNameDescription
OTHERNon-interventionNon-intervention,with real world study

Timeline

Start date
2022-08-30
Primary completion
2023-08-30
Completion
2027-03-31
First posted
2022-07-29
Last updated
2022-07-29

Source: ClinicalTrials.gov record NCT05480189. Inclusion in this directory is not an endorsement.

Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective (NCT05480189) · Clinical Trials Directory